Your browser doesn't support javascript.
loading
Inhibition of miR-21 Regulates Mutant KRAS Effector Pathways and Intercepts Pancreatic Ductal Adenocarcinoma Development.
Chu, Nina J; Anders, Robert A; Fertig, Elana J; Cao, Minwei; Hopkins, Alexander C; Keenan, Bridget P; Popovic, Aleksandra; Armstrong, Todd D; Jaffee, Elizabeth M; Zimmerman, Jacquelyn W.
Afiliação
  • Chu NJ; Department of Oncology, Skip Viragh Center for Pancreas Cancer, Bloomberg Kimmel Institute for Cancer Immunotherapy, and the Sidney Kimmel Cancer Center at Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Anders RA; Department of Oncology, Skip Viragh Center for Pancreas Cancer, Bloomberg Kimmel Institute for Cancer Immunotherapy, and the Sidney Kimmel Cancer Center at Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Fertig EJ; Department of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland.
  • Cao M; Department of Oncology, Skip Viragh Center for Pancreas Cancer, Bloomberg Kimmel Institute for Cancer Immunotherapy, and the Sidney Kimmel Cancer Center at Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Hopkins AC; Department of Applied Mathematics and Statistics, Whiting School of Engineering, Johns Hopkins University, Baltimore, Maryland.
  • Keenan BP; Department of Biomedical Engineering, Johns Hopkins School of Medicine, Baltimore, Maryland.
  • Popovic A; Department of Oncology, Skip Viragh Center for Pancreas Cancer, Bloomberg Kimmel Institute for Cancer Immunotherapy, and the Sidney Kimmel Cancer Center at Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Armstrong TD; Department of Oncology, Skip Viragh Center for Pancreas Cancer, Bloomberg Kimmel Institute for Cancer Immunotherapy, and the Sidney Kimmel Cancer Center at Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Jaffee EM; Department of Oncology, Skip Viragh Center for Pancreas Cancer, Bloomberg Kimmel Institute for Cancer Immunotherapy, and the Sidney Kimmel Cancer Center at Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Zimmerman JW; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California.
Cancer Prev Res (Phila) ; 13(7): 569-582, 2020 07.
Article em En | MEDLINE | ID: mdl-32409593
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Proteínas Proto-Oncogênicas p21(ras) / Carcinoma Ductal Pancreático / MicroRNAs / Mutação Limite: Animals / Humans Idioma: En Revista: Cancer Prev Res (Phila) Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Proteínas Proto-Oncogênicas p21(ras) / Carcinoma Ductal Pancreático / MicroRNAs / Mutação Limite: Animals / Humans Idioma: En Revista: Cancer Prev Res (Phila) Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article